JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bortolotti, U.
Right arrow Articles by Gallucci, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bortolotti, U.
Right arrow Articles by Gallucci, V.

The Journal of Thoracic and Cardiovascular Surgery, Vol 90, 564-569, Copyright © 1985 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Results of reoperation for primary tissue failure of porcine bioprostheses

U Bortolotti, A Milano, A Mazzucco, C Valfre, E Talenti, F Guerra, G Thiene and V Gallucci

Results of reoperation for primary tissue failure of porcine bioprostheses were evaluated in 574 patients discharged from the hospital from 1970 to 1981. A total of 413 had undergone isolated mitral valve replacement and 161 isolated aortic valve replacement. Through March, 1984, 88 patients (15%) had required reoperation: 59 had undergone mitral and 29, aortic valve replacement. Primary tissue failure was the main cause of bioprosthetic dysfunction; it occurred in 64 patients (46 mitral and 18 aortic) at a mean postoperative interval of 93 +/- 4 months (range 34 to 158). During the same period, 11 patients required reoperation for bioprosthetic endocarditis, 11 for paravalvular leak, and two for thrombosis. These patients are not included in this review. Reoperation for primary tissue failure was performed after a mean interval of 72 +/- 6 months (range 38 to 158) for patients with aortic bioprostheses and after 101 +/- 5 months (range 34 to 153) for those with mitral bioprostheses (p less than 0.05). Overall mortality at reoperation was 12.5%: 11% for the mitral group and 16% for the aortic group. In 62 patients (45 mitral and 17 aortic) primary tissue failure was caused by calcification of the cusps, associated with severe fibrous tissue overgrowth in seven. Bioprosthetic failure was caused by an intracuspal hematoma in one patient with mitral valve replacement and by lipid infiltration of the cusps in one patient with aortic valve replacement. Actuarial freedom from bioprosthetic primary tissue failure at 12 years is 61% +/- 5% for the mitral group and 69% +/- 7% for the aortic group. On the basis of our long-term follow-up of patients after mitral or aortic replacement with a porcine bioprosthesis, we conclude: primary tissue failure is the most frequent indication for reoperation in patients with a porcine bioprosthesis; calcification of the cusp tissue is the leading cause of primary tissue failure; reoperation for primary tissue failure may be a major concern, although mortality for elective cases is low; and the limited durability of porcine bioprostheses suggests their use be restricted to selected patients.


This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. Rizzoli, T. Bottio, G. Thiene, G. Toscano, and D. Casarotto
Long-term durability of the Hancock II porcine bioprosthesis
J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 66 - 74.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. D. Hopper, I. C. Gilchrist, J. R. Landis, A. H. Abolfathi, A. Russell Localio, R. P. Wilson, W. E. Pae Jr., A. R. Kunselman, D. W. Wieting, J. W. Griffith, et al.
In Vivo Accuracy Of Two Radiographic Systems In The Detection Of Bjork-Shiley Convexo-Concave Heart Valve Outlet Strut Single Leg Separations
J. Thorac. Cardiovasc. Surg., March 1, 1998; 115(3): 582 - 586.
[Abstract] [Full Text]


Home page
NEJMHome page
W. Vongpatanasin, L. D. Hillis, and R. A. Lange
Prosthetic Heart Valves
N. Engl. J. Med., August 8, 1996; 335(6): 407 - 416.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Dunmore-Buyze, D. R. Boughner, N. Macris, and I. Vesely
A COMPARISON OF MACROSCOPIC LIPID CONTENT WITHIN PORCINE PULMONARY AND AORTIC VALVES: Implications for bioprosthetic valves
J. Thorac. Cardiovasc. Surg., December 1, 1995; 110(6): 1756 - 1761.
[Abstract] [Full Text]


Home page
Eur. J. Cardiothorac. Surg.Home page
U. Bortolotti, A. Milano, G. Thiene, and A. Mazzucco
Original expectations of the Hancock valve and 20 years of clinical reality
Eur. J. Cardiothorac. Surg., January 1, 1992; 6(suppl_1): S75 - S78.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1985 by The American Association for Thoracic Surgery.